April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Agenus announced new data highlighting BOT/BAL across multiple lines of treatment in Colorectal Cancer
Jan 23, 2025, 12:00

Agenus announced new data highlighting BOT/BAL across multiple lines of treatment in Colorectal Cancer

Agenus shared on LinkedIn:

“Today, we announced new data highlighting BOT/BAL across multiple lines of treatment in Colorectal Cancer.

Find the details of our five ASCO GI presentations here.”

Further Reading:

Three decades of pioneering in Immune Oncology – Agenus

Botensilimab: A Revolutionary Fc-Enhanced CTLA-4 Inhibitor Transforming Cancer Immunotherapy

Botensilimab’s mechanism of action and potential in addressing treatment-resistant cancers

New Paper Alert! Promising Results for MSS Colorectal Cancer Treated with Balstilimab and Botensilimab

Agenus has Announced Five Presentations at 2025 ASCO GI Highlighting BOT/BAL Activity Across Colorectal and Gastric Cancers